Discovering new medicines by combining ultra throughput biochemistry and machine learning.
Location: United States, California, San Francisco
Employees: 11-50
Total raised: $30M
Founded date: 2019
Investors 6
| Date | Name | Website |
| - | Air Street... | airstreet.... |
| 26.11.2020 | Lux Capita... | luxcapital... |
| - | age1 | age1.com |
| 25.05.2023 | Expedition... | expedition... |
| - | Catalio Ca... | cataliocap... |
| - | Sahsen Ven... | sahsen.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.06.2022 | Series A | $30M | Catalio Ca... |
Mentions in press and media 5
| Date | Title | Description |
| 18.12.2023 | Anagenex and Nimbus Announce a Multi-Target Collaboration to Discover Small Molecule Therapeutics for Multiple Indications | Anagenex and Nimbus Therapeutics (Nimbus) announced they have initiated a research collaboration. Anagenex, a pioneering drug discovery company pairing large-scale data generation with proprietary artificial intelligence (AI), will work clo... |
| 09.06.2022 | Anagenex Closes $30 Million Series A Round led by Catalio to Advance Small Molecule Drug Discovery with a Novel, Directed Evolution Platform | Anagenex, a pioneering drug discovery company pairing large-scale data generation with machine learning to discover the next generation of small molecule medicines, announced that it has closed a $30 million Series A financing round led by ... |
| 09.06.2022 | ARK’s Cathie Wood weighs in on venture capital and her plans to launch a crossover fund | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Venture capitalists may be predicting trouble ahead for the private markets—but Cathie Wood has a... |
| 08.06.2022 | Anagenex Closes $30M Series A Round | SAN FRANCISCO, CA, Anagenex, a pioneering drug discovery company, has closed a $30 million Series A financing round led by Catalio Capital Management. >> Click here for more funding data on Anagenex >> To export Anagenex fun... |
| 08.06.2022 | Anagenex Raises $30M in Series A Funding | Anagenex, a San Francisco Bay area and Woburn, Mass.-based drug discovery company pairing large-scale data generation with machine learning to discover the next generation of small molecule medicines, closed a $30m Series A financing. The r... |